Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

NCT00117702 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped safety reasons

Conditions

Graft vs Host Disease

Interventions

DRUG: Tacrolimus
DRUG: Everolimus

Sponsor

Technische Universität Dresden